VanDeusen JB - Search Results

1

Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy.

Fehniger TA, Bluman EM, Porter MM, Mrózek E, Cooper MA, VanDeusen JB, Frankel SR, Stock W, Caligiuri MA. Fehniger TA, et al. Among authors: vandeusen jb. J Clin Invest. 2000 Jul;106(1):117-24. doi: 10.1172/JCI6218. J Clin Invest. 2000. PMID: 10880055 Free PMC article.

2

In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells.

Cooper MA, Bush JE, Fehniger TA, VanDeusen JB, Waite RE, Liu Y, Aguila HL, Caligiuri MA. Cooper MA, et al. Among authors: vandeusen jb. Blood. 2002 Nov 15;100(10):3633-8. doi: 10.1182/blood-2001-12-0293. Epub 2002 Jul 5. Blood. 2002. PMID: 12393617 Free article.

3

Biology and clinical impact of human natural killer cells.

Farag SS, VanDeusen JB, Fehniger TA, Caligiuri MA. Farag SS, et al. Among authors: vandeusen jb. Int J Hematol. 2003 Jul;78(1):7-17. doi: 10.1007/BF02983234. Int J Hematol. 2003. PMID: 12894845 Review.

4

Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.

Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA. Fehniger TA, et al. Among authors: vandeusen jb. J Immunol. 1999 Apr 15;162(8):4511-20. J Immunol. 1999. PMID: 10201989

5

New developments in anti-tumor efficacy and malignant transformation of human natural killer cells.

VanDeusen JB, Caligiuri MA. VanDeusen JB, et al. Curr Opin Hematol. 2003 Jan;10(1):55-9. doi: 10.1097/00062752-200301000-00009. Curr Opin Hematol. 2003. PMID: 12483112 Review.

6

Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells.

Fehniger TA, Suzuki K, Ponnappan A, VanDeusen JB, Cooper MA, Florea SM, Freud AG, Robinson ML, Durbin J, Caligiuri MA. Fehniger TA, et al. Among authors: vandeusen jb. J Exp Med. 2001 Jan 15;193(2):219-31. doi: 10.1084/jem.193.2.219. J Exp Med. 2001. PMID: 11208862 Free PMC article.

7

Fatal leukemia in interleukin-15 transgenic mice.

Fehniger TA, Suzuki K, VanDeusen JB, Cooper MA, Freud AG, Caligiuri MA. Fehniger TA, et al. Among authors: vandeusen jb. Blood Cells Mol Dis. 2001 Jan-Feb;27(1):223-30. doi: 10.1006/bcmd.2001.0379. Blood Cells Mol Dis. 2001. PMID: 11358383 Review.

8

A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.

Yokohama A, Mishra A, Mitsui T, Becknell B, Johns J, Curphey D, Blaser BW, Vandeusen JB, Mao H, Yu J, Caligiuri MA. Yokohama A, et al. Among authors: vandeusen jb. Leuk Res. 2010 Feb;34(2):203-9. doi: 10.1016/j.leukres.2009.06.031. Epub 2009 Aug 5. Leuk Res. 2010. PMID: 19660811 Free PMC article.

9

In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis.

Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA. Guimond M, et al. Among authors: vandeusen jb. J Immunol. 2010 Mar 15;184(6):2769-75. doi: 10.4049/jimmunol.0900685. Epub 2010 Feb 8. J Immunol. 2010. PMID: 20142363 Free PMC article.

10

Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection.

Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA. Nguyen KB, et al. J Immunol. 2002 Oct 15;169(8):4279-87. doi: 10.4049/jimmunol.169.8.4279. J Immunol. 2002. PMID: 12370359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page